成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

  1. JAK/STAT Signaling Stem Cell/Wnt Apoptosis Anti-infection
  2. STAT Ferroptosis Parasite Virus Protease
  3. Artesunate

Artesunate  (Synonyms: 青蒿琥酯)

目錄號: HY-N0193 純度: 99.84%
COA 產(chǎn)品使用指南

Artesunate 是 STAT-3 和輸出蛋白 1 (EXP1) 的抑制劑。

MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報,我們不為任何個人用途提供產(chǎn)品和服務(wù)

Artesunate Chemical Structure

Artesunate Chemical Structure

CAS No. : 88495-63-0

1.  客戶無需承擔(dān)相應(yīng)的運輸費用。

2.  同一機構(gòu)(單位)同一產(chǎn)品試用裝僅限申領(lǐng)一次,同一機構(gòu)(單位)一年內(nèi)

     可免費申領(lǐng)三個不同產(chǎn)品的試用裝。

3.  試用裝只面向終端客戶

規(guī)格 價格 是否有貨 數(shù)量
10 mM * 1 mL in DMSO ¥550
In-stock
50 mg ¥500
In-stock
100 mg ¥800
In-stock
200 mg ¥1360
In-stock
500 mg ¥2856
In-stock
1 g ¥4569
In-stock
5 g   詢價  
10 g   詢價  

* Please select Quantity before adding items.

Customer Review

Other Forms of Artesunate:

    Artesunate purchased from MCE. Usage Cited in: Basic Clin Pharmacol Toxicol. 2022 Nov 26.  [Abstract]

    Artesunate (ART; 1, 2 μM) significantly reduces cell viability in RAW264.7 cells in the presence of RANKL but does not influence undifferentiating cells.
    • 生物活性

    • 實驗參考方法

    • 純度 & 產(chǎn)品資料

    • 參考文獻

    生物活性

    Artesunate is an inhibitor of both STAT-3 and exported protein 1 (EXP1).

    IC50 & Target[1][2]

    Stat-3

     

    EXP1

     

    細胞效力
    (Cellular Effect)
    Cell Line Type Value Description References
    A549 IC50
    15.921 μM
    Compound: 1; ART
    Antiproliferative activity against human A549 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human A549 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    [PMID: 26615886]
    A549 IC50
    5.4 μM
    Compound: 3; ARS
    Cytotoxicity against human A549 cells assessed as reduction in cell viability by MTT assay
    Cytotoxicity against human A549 cells assessed as reduction in cell viability by MTT assay
    [PMID: 33691167]
    A549 IC50
    50.68 μM
    Compound: ATS
    Antiproliferative activity against human A549 cells measured after 48 hrs by MTT assay
    Antiproliferative activity against human A549 cells measured after 48 hrs by MTT assay
    [PMID: 30837097]
    ADR5000 cell line EC50
    0.1 μM
    Compound: 2
    Cytotoxicity against human CEM/ADR5000 cells overexpressing P-gp assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    Cytotoxicity against human CEM/ADR5000 cells overexpressing P-gp assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    [PMID: 29937978]
    ADR5000 cell line EC50
    0.189 μM
    Compound: 3
    Cytotoxicity against human CEM/ADR5000 cells over-expressing P-gp assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    Cytotoxicity against human CEM/ADR5000 cells over-expressing P-gp assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    [PMID: 29887512]
    ADR5000 cell line IC50
    0.19 μM
    Compound: 3
    Cytotoxicity against human CEM/ADR5000 cells assessed as cell viability after 72 hrs by resazurin assay
    Cytotoxicity against human CEM/ADR5000 cells assessed as cell viability after 72 hrs by resazurin assay
    [PMID: 26260339]
    ADR5000 cell line IC50
    1.2 μM
    Compound: 1
    Cytotoxicity against human CEM/ADR5000 by CCK-8 assay
    Cytotoxicity against human CEM/ADR5000 by CCK-8 assay
    [PMID: 22884578]
    ADR5000 cell line IC50
    1.2 μM
    Compound: 2
    Cytotoxicity against human multidrug-resistant CEM/ADR5000 cells expressing p-glycoprotein by resazurin assay
    Cytotoxicity against human multidrug-resistant CEM/ADR5000 cells expressing p-glycoprotein by resazurin assay
    [PMID: 24561670]
    ADR5000 cell line IC50
    1.2 μM
    Compound: 1
    Cytotoxicity against human CEM/ADR5000 by XTT assay
    Cytotoxicity against human CEM/ADR5000 by XTT assay
    [PMID: 20527917]
    BT-474 IC50
    7.8 μM
    Compound: Artesunate
    Cytotoxicity against human BT474 cells after 48 hrs by MTT assay
    Cytotoxicity against human BT474 cells after 48 hrs by MTT assay
    [PMID: 23790541]
    C-33-A EC50
    1.83 μM
    Compound: 7
    Antiproliferative activity against human C33A cells after 72 hrs by MTT assay
    Antiproliferative activity against human C33A cells after 72 hrs by MTT assay
    [PMID: 30429957]
    CCRF-CEM EC50
    0.069 μM
    Compound: 3
    Cytotoxicity against human CCRF-CEM cells assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    Cytotoxicity against human CCRF-CEM cells assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    [PMID: 29887512]
    CCRF-CEM IC50
    0.07 μM
    Compound: 3
    Cytotoxicity against human CCRF-CEM cells assessed as cell viability after 72 hrs by resazurin assay
    Cytotoxicity against human CCRF-CEM cells assessed as cell viability after 72 hrs by resazurin assay
    [PMID: 26260339]
    CCRF-CEM EC50
    0.4 μM
    Compound: 2
    Cytotoxicity against human CCRF-CEM cells assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    Cytotoxicity against human CCRF-CEM cells assessed as reduction in cell viability after 72 hrs by resazurin dye based assay
    [PMID: 29937978]
    CCRF-CEM IC50
    1.8 μM
    Compound: 1
    Cytotoxicity against human CCRF-CEM cells by CCK-8 assay
    Cytotoxicity against human CCRF-CEM cells by CCK-8 assay
    [PMID: 22884578]
    CCRF-CEM IC50
    1.8 μM
    Compound: 2
    Cytotoxicity against human CCRF-CEM cells by resazurin assay
    Cytotoxicity against human CCRF-CEM cells by resazurin assay
    [PMID: 24561670]
    CCRF-CEM IC50
    1.8 μM
    Compound: 1
    Cytotoxicity against human CCRF-CEM by XTT assay
    Cytotoxicity against human CCRF-CEM by XTT assay
    [PMID: 20527917]
    CHO IC50
    > 100 μM
    Compound: ARS
    Cytotoxicity against CHO cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
    Cytotoxicity against CHO cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
    [PMID: 27448920]
    HCT-116 IC50
    0.89 μM
    Compound: AS
    Antiproliferative activity against human HCT116 cells assessed as inhibition of cell viability after 48 hrs by MTS assay
    Antiproliferative activity against human HCT116 cells assessed as inhibition of cell viability after 48 hrs by MTS assay
    [PMID: 31494469]
    HCT-116 IC50
    7.1 μM
    Compound: Artesunate
    Antiproliferative activity against human HCT-116 cells assessed as growth after 48 hrs by MTT assay
    Antiproliferative activity against human HCT-116 cells assessed as growth after 48 hrs by MTT assay
    [PMID: 27010926]
    HEK293 IC50
    10 μM
    Compound: Artesunate
    Cytotoxicity against HEK293 cells assessed as cell growth inhibition after 72 hrs by Alamar blue assay
    Cytotoxicity against HEK293 cells assessed as cell growth inhibition after 72 hrs by Alamar blue assay
    [PMID: 28774427]
    HEK293 IC50
    2.9 μM
    Compound: artesunate
    Cytotoxicity against human HEK293 cells after 72 hrs by alamar blue assay
    Cytotoxicity against human HEK293 cells after 72 hrs by alamar blue assay
    [PMID: 21155593]
    HEK293 IC50
    7 μM
    Compound: Artesunate
    Cytotoxicity against HEK293 cells after 72 hrs by resazurin dye based assay
    Cytotoxicity against HEK293 cells after 72 hrs by resazurin dye based assay
    [PMID: 29236492]
    HeLa IC50
    0.5 μM
    Compound: Artesunate
    Cytotoxicity against human HeLa cells assessed as cell viability incubated for 48 hrs by MTT assay
    Cytotoxicity against human HeLa cells assessed as cell viability incubated for 48 hrs by MTT assay
    [PMID: 31945642]
    HeLa EC50
    12.03 μM
    Compound: 7
    Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
    Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay
    [PMID: 30429957]
    HeLa IC50
    19.014 μM
    Compound: 1; ART
    Antiproliferative activity against human HeLa cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human HeLa cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    [PMID: 26615886]
    HeLa IC50
    3.2 μM
    Compound: Artesunate
    Cytotoxicity against human HeLa cells incubated for 48 hrs by resazurin dye reduction assay
    Cytotoxicity against human HeLa cells incubated for 48 hrs by resazurin dye reduction assay
    [PMID: 23013253]
    HeLa IC50
    7.1 μM
    Compound: Artesunate
    Antiproliferative activity against human Hela cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    Antiproliferative activity against human Hela cells assessed as cell growth inhibition measured after 48 hrs by MTT assay
    [PMID: 27010926]
    HepG2 IC50
    < 1 μM
    Compound: Artesunate
    Antimalarial activity against sporozoite stage of Plasmodium yoelii assessed as invasion of human HepG2 cells expressing CD81 incubated for 2 hrs prior to inoculation measured after 1 hr by immunofluorescence assay in presence of penicillin/streptomycin
    Antimalarial activity against sporozoite stage of Plasmodium yoelii assessed as invasion of human HepG2 cells expressing CD81 incubated for 2 hrs prior to inoculation measured after 1 hr by immunofluorescence assay in presence of penicillin/streptomycin
    [PMID: 23927658]
    HepG2 IC50
    12.7 μM
    Compound: artesunate
    Cytotoxicity against human HepG2 cells after 72 hrs by alamar blue assay
    Cytotoxicity against human HepG2 cells after 72 hrs by alamar blue assay
    [PMID: 21155593]
    HepG2 IC50
    20 μM
    Compound: ARS
    Cytotoxicity against human HepG2 cells after 72 hrs by formazan test
    Cytotoxicity against human HepG2 cells after 72 hrs by formazan test
    [PMID: 23685181]
    HepG2 IC50
    22.24 μM
    Compound: 1; ART
    Antiproliferative activity against human HepG2 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human HepG2 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    [PMID: 26615886]
    HepG2 IC50
    267 μM
    Compound: Artesunate
    Cytotoxicity against human HepG2 cells assessed as cell viability after 72 hrs by MTT assay
    Cytotoxicity against human HepG2 cells assessed as cell viability after 72 hrs by MTT assay
    [PMID: 33158577]
    HepG2 IC50
    39.93 μM
    Compound: ATS
    Antiproliferative activity against human HepG2 cells measured after 48 hrs by MTT assay
    Antiproliferative activity against human HepG2 cells measured after 48 hrs by MTT assay
    [PMID: 30837097]
    HepG2 IC50
    47 μM
    Compound: 3; ARS
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by MTT assay
    Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by MTT assay
    [PMID: 33691167]
    HepG2 IC50
    59.4 μM
    Compound: Artesunate
    Antiproliferative activity against human HepG2 cells by MTT assay
    Antiproliferative activity against human HepG2 cells by MTT assay
    [PMID: 31546197]
    HepG2 IC50
    6.5 μM
    Compound: ART
    Dark toxicity against human HepG2 cells assessed as reduction in cell viability incubated overnight by MTT assay
    Dark toxicity against human HepG2 cells assessed as reduction in cell viability incubated overnight by MTT assay
    [PMID: 28882481]
    HepG2 IC50
    7.7 μM
    Compound: ART
    Phototoxicity against human HepG2 cells assessed as reduction in cell viability preincubated overnight followed by irradiation with LED light at 1.7 J/cm'2 for 10 mins measured post overnight incubation by MTT assay
    Phototoxicity against human HepG2 cells assessed as reduction in cell viability preincubated overnight followed by irradiation with LED light at 1.7 J/cm'2 for 10 mins measured post overnight incubation by MTT assay
    [PMID: 28882481]
    HepG2 2.2.15 IC50
    2.3 μM
    Compound: 21
    Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV surface antigen secretion after 21 days
    Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV surface antigen secretion after 21 days
    [PMID: 24549242]
    HL-60 IC50
    2 μM
    Compound: ASN
    Cytotoxicity against human HL60 cells assessed as cell viability after 24 hrs by MTT assay
    Cytotoxicity against human HL60 cells assessed as cell viability after 24 hrs by MTT assay
    [PMID: 24148834]
    Huh-7 CC50
    > 100 μg/mL
    Compound: AS
    Cytotoxicity against human Huh-7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    Cytotoxicity against human Huh-7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
    [PMID: 36306538]
    HUVEC IC50
    1.092 μM
    Compound: 1; ART
    Antiproliferative activity against HUVEC assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against HUVEC assessed as growth inhibition after 72 hrs by CCK-8 assay
    [PMID: 26615886]
    HUVEC IC50
    86.1 μM
    Compound: 3; ARS
    Cytotoxicity against HUVEC assessed as reduction in cell viability by MTT assay
    Cytotoxicity against HUVEC assessed as reduction in cell viability by MTT assay
    [PMID: 33691167]
    J82 IC50
    75.7 μM
    Compound: 3; ARS
    Cytotoxicity in human J82 cells assessed as reduction in cell viability by MTT assay
    Cytotoxicity in human J82 cells assessed as reduction in cell viability by MTT assay
    [PMID: 33691167]
    K562 IC50
    5.999 μM
    Compound: 1; ART
    Antiproliferative activity against human K562 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human K562 cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    [PMID: 26615886]
    K562/Adr IC50
    6.256 μM
    Compound: 1; ART
    Antiproliferative activity against human K562/ADR cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    Antiproliferative activity against human K562/ADR cells assessed as growth inhibition after 72 hrs by CCK-8 assay
    [PMID: 26615886]
    KB IC50
    78.5 μM
    Compound: Artesunate
    Antiproliferative activity against human KB cells by MTT assay
    Antiproliferative activity against human KB cells by MTT assay
    [PMID: 31546197]
    L02 IC50
    72.17 μM
    Compound: ATS
    Cytotoxicity against human L02 cells measured after 48 hrs by MTT assay
    Cytotoxicity against human L02 cells measured after 48 hrs by MTT assay
    [PMID: 30837097]
    L6 IC50
    1.5 μM
    Compound: Artesunate
    Cytotoxicity against rat L6 cells incubated for 690 hrs by Alamar blue assay
    Cytotoxicity against rat L6 cells incubated for 690 hrs by Alamar blue assay
    [PMID: 23013253]
    L6 IC50
    24 μM
    Compound: AS
    Cytotoxicity against rat L6 cells after 72 hrs by alamar blue assay
    Cytotoxicity against rat L6 cells after 72 hrs by alamar blue assay
    [PMID: 25195945]
    L6 IC50
    6.63 μM
    Compound: 2
    Cytotoxicity in rat L6 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue dye based assay
    Cytotoxicity in rat L6 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue dye based assay
    [PMID: 28988153]
    LS174T IC50
    10 μM
    Compound: ARS
    Cytotoxicity against human LS 174T cells after 72 hrs by formazan test
    Cytotoxicity against human LS 174T cells after 72 hrs by formazan test
    [PMID: 23685181]
    MCF-10A IC50
    21 μM
    Compound: Artesunate
    Cytotoxicity against human MCF10A cells after 48 hrs by MTT assay
    Cytotoxicity against human MCF10A cells after 48 hrs by MTT assay
    [PMID: 23790541]
    MCF7 IC50
    38.71 μM
    Compound: ATS
    Antiproliferative activity against human MCF7 cells measured after 48 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells measured after 48 hrs by MTT assay
    [PMID: 30837097]
    MCF7 EC50
    4.21 μM
    Compound: 7
    Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
    Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
    [PMID: 30429957]
    MDA-MB-231 EC50
    10.04 μM
    Compound: 7
    Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by MTT assay
    Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by MTT assay
    [PMID: 30429957]
    MDA-MB-231 IC50
    46 μM
    Compound: Artesunate
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    Cytotoxicity against human MDA-MB-231 cells after 48 hrs by MTT assay
    [PMID: 23790541]
    MDA-MB-231 IC50
    75.69 μM
    Compound: ATS
    Antiproliferative activity against human MDA-MB-231 cells measured after 48 hrs by MTT assay
    Antiproliferative activity against human MDA-MB-231 cells measured after 48 hrs by MTT assay
    [PMID: 30837097]
    MDA-MB-361 EC50
    2.27 μM
    Compound: 7
    Antiproliferative activity against human MDA-MB-361 cells after 72 hrs by MTT assay
    Antiproliferative activity against human MDA-MB-361 cells after 72 hrs by MTT assay
    [PMID: 30429957]
    MRC5 IC50
    6.8 μM
    Compound: Artesunate
    Cytotoxicity against human MRC5 cells incubated for 48 hrs by resazurin dye reduction assay
    Cytotoxicity against human MRC5 cells incubated for 48 hrs by resazurin dye reduction assay
    [PMID: 23013253]
    OVCAR-3 IC50
    67.3 μM
    Compound: 3; ARS
    Cytotoxicity against human OVCAR3 cells assessed as reduction in cell viability by MTT assay
    Cytotoxicity against human OVCAR3 cells assessed as reduction in cell viability by MTT assay
    [PMID: 33691167]
    SiHa EC50
    > 30 μM
    Compound: 7
    Antiproliferative activity against human SiHa cells after 72 hrs by MTT assay
    Antiproliferative activity against human SiHa cells after 72 hrs by MTT assay
    [PMID: 30429957]
    SK-HEP1 IC50
    10 μM
    Compound: ARS
    Cytotoxicity against human SKHEP1 cells after 72 hrs by formazan test
    Cytotoxicity against human SKHEP1 cells after 72 hrs by formazan test
    [PMID: 23685181]
    SMMC-7721 IC50
    72.3 μM
    Compound: 3; ARS
    Cytotoxicity against human SMMC-7721 cells assessed as reduction in cell viability by MTT assay
    Cytotoxicity against human SMMC-7721 cells assessed as reduction in cell viability by MTT assay
    [PMID: 33691167]
    T47D EC50
    2.22 μM
    Compound: 7
    Antiproliferative activity against human T47D cells after 72 hrs by MTT assay
    Antiproliferative activity against human T47D cells after 72 hrs by MTT assay
    [PMID: 30429957]
    WI-38 IC50
    > 100 μM
    Compound: ARS
    Cytotoxicity against human WI38 cells assessed as reduction in cell viability measured after 48 hrs by SRB assay
    Cytotoxicity against human WI38 cells assessed as reduction in cell viability measured after 48 hrs by SRB assay
    [PMID: 27448920]
    WI-38 IC50
    > 100 μM
    Compound: Artesunate
    Cytotoxicity against human WI38 cells assessed as growth inhibition after 48 hrs by sulforhodamine B assay
    Cytotoxicity against human WI38 cells assessed as growth inhibition after 48 hrs by sulforhodamine B assay
    [PMID: 27210430]
    WM 266-4 IC50
    8.46 μM
    Compound: AS
    Antiproliferative activity against human WM266.4 cells assessed as inhibition of cell viability after 48 hrs by MTS assay
    Antiproliferative activity against human WM266.4 cells assessed as inhibition of cell viability after 48 hrs by MTS assay
    [PMID: 31494469]
    體外研究
    (In Vitro)

    Artesunate 是 STAT-3 和輸出蛋白 1 (EXP1) 的抑制劑[1][2]。Artesunate 處理 24 小時會導(dǎo)致兩種細胞系中活性氧 (ROS) 水平以劑量依賴性方式顯著增加。此外,蛋白質(zhì)印跡法顯示,當(dāng)癌細胞在較高劑量范圍內(nèi)用 Artesunate 處理 24 小時時,γ-H2AX 水平顯著升高。Artesunate 還表現(xiàn)出對 A2780 和 HO8910 細胞中 RAD51 水平的時間依賴性影響。在兩種非惡性細胞(正常人成纖維細胞和永生化上皮細胞 FTE-187)中,Artesunate 不會改變 RAD51 的水平。在 A2780 細胞中,RAD51 mRNA 水平確實因 Artesunate 的加入而降低,且呈劑量依賴性。相應(yīng)地,RAD51 的啟動子活性被青蒿琥酯顯著抑制。相反,H8910 細胞中的 RAD51 mRNA 水平不受 Artesunate 的影響[3]。

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    體內(nèi)研究
    (In Vivo)

    Artesunate 與順鉑聯(lián)合治療組腫瘤生長明顯減少(P<0.01)。相比之下,Artesunate 單獨治療對兩種細胞系腫瘤異種移植的生長無顯著影響[3]。

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Clinical Trial
    分子量

    384.42

    Formula

    C19H28O8

    CAS 號
    性狀

    固體

    顏色

    White to off-white

    中文名稱

    青蒿酯;青蒿琥酯;二氫青蒿素-12-α-丁二酸單酯;

    結(jié)構(gòu)分類
    初始來源
    運輸條件

    Room temperature in continental US; may vary elsewhere.

    儲存方式
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 6 months
    -20°C 1 month
    溶解性數(shù)據(jù)
    細胞實驗: 

    DMSO 中的溶解度 : 83.33 mg/mL (216.77 mM; 超聲助溶; 吸濕的 DMSO 對產(chǎn)品的溶解度有顯著影響,請使用新開封的 DMSO)

    7.5% Sodium bicarbonate 中的溶解度 : 2 mg/mL (5.20 mM; 超聲助溶 (<60°C))

    H2O 中的溶解度 : < 0.1 mg/mL (insoluble)

    配制儲備液
    濃度 溶劑體積 質(zhì)量 1 mg 5 mg 10 mg
    1 mM 2.6013 mL 13.0066 mL 26.0132 mL
    5 mM 0.5203 mL 2.6013 mL 5.2026 mL
    查看完整儲備液配制表

    * 請根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲備液;一旦配成溶液,請分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。
    儲備液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C儲存時,請在6個月內(nèi)使用,-20°C儲存時,請在1個月內(nèi)使用。

    • 摩爾計算器

    • 稀釋計算器

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    質(zhì)量
    =
    濃度
    ×
    體積
    ×
    分子量 *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    濃度 (start)

    C1

    ×
    體積 (start)

    V1

    =
    濃度 (final)

    C2

    ×
    體積 (final)

    V2

    動物實驗:

    請根據(jù)您的 實驗動物和給藥方式 選擇適當(dāng)?shù)娜芙夥桨浮?

    以下溶解方案都請先按照 In Vitro 方式配制澄清的儲備液,再依次添加助溶劑:
    ——為保證實驗結(jié)果的可靠性,澄清的儲備液可以根據(jù)儲存條件,適當(dāng)保存;體內(nèi)實驗的工作液,建議您現(xiàn)用現(xiàn)配,當(dāng)天使用;
    以下溶劑前顯示的百分比是指該溶劑在您配制終溶液中的體積占比;如在配制過程中出現(xiàn)沉淀、析出現(xiàn)象,可以通過加熱和/或超聲的方式助溶

    • 方案 一

      請依序添加每種溶劑: 10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.08 mg/mL (5.41 mM); 澄清溶液

      此方案可獲得 ≥ 2.08 mg/mL(飽和度未知)的澄清溶液。

      1 mL 工作液為例,取 100 μL 20.8 mg/mL 的澄清 DMSO 儲備液加到 400 μL PEG300 中,混合均勻;再向上述體系中加入 50 μL Tween-80,混合均勻;然后再繼續(xù)加入 450 μL 生理鹽水 定容至 1 mL。

      生理鹽水的配制:將 0.9 g 氯化鈉,溶解于 ddH?O 并定容至 100 mL,可以得到澄清透明的生理鹽水溶液。
    • 方案 二

      請依序添加每種溶劑: 10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 2.08 mg/mL (5.41 mM); 澄清溶液

      此方案可獲得 ≥ 2.08 mg/mL(飽和度未知)的澄清溶液。

      1 mL 工作液為例,取 100 μL 20.8 mg/mL 的澄清 DMSO 儲備液加到 900 μL 20% 的 SBE-β-CD 生理鹽水水溶液 中,混合均勻。

      2 g SBE-β-CD(磺丁基醚 β-環(huán)糊精)粉末定容于 10 mL 的生理鹽水中,完全溶解至澄清透明。
    動物溶解方案計算器
    請輸入動物實驗的基本信息:

    給藥劑量

    mg/kg

    動物的平均體重

    g

    每只動物的給藥體積

    μL

    動物數(shù)量

    由于實驗過程有損耗,建議您多配一只動物的量
    請輸入您的動物體內(nèi)配方組成:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    如果您的動物是免疫缺陷鼠或者體弱鼠,建議 DMSO 中的在最后工作液體系中的占比盡量不超過 2%。
    方案所需 助溶劑 包括:DMSO, ,均可在 MCE 網(wǎng)站選購。 ,Tween 80,均可在 MCE 網(wǎng)站選購。
    計算結(jié)果
    工作液所需濃度 : mg/mL
    儲備液配制方法 : mg 藥物溶于 μL  DMSO(母液濃度為 mg/mL)。
    您所需的儲備液濃度超過該產(chǎn)品的實測溶解度,以下方案僅供參考,如有需要,請與 MCE 中國技術(shù)支持聯(lián)系。
    動物實驗體內(nèi)工作液的配制方法 : 取 μL DMSO 儲備液,加入 μL 。 μL ,混合均勻至澄清,再加 μL Tween 80,混合均勻至澄清,再加 μL 生理鹽水。
    連續(xù)給藥周期超過半月以上,請謹慎選擇該方案。
    請確保第一步儲備液溶解至澄清狀態(tài),從左到右依次添加助溶劑。您可采用超聲加熱 (超聲清洗儀,建議頻次 20-40 kHz),渦旋吹打等方式輔助溶解。
    純度 & 產(chǎn)品資料

    純度: 99.84%

    參考文獻
    Kinase Assay
    [3]

    After treatment with Artesunate for 24 h, cells are harvested and lysed in 1×cell lysis buffer. Total proteins of 15 to 25 μg are separated by SDS-PAGE and transferred to polyvinylidenedifluoride (PVDF) membranes. Membranes are blocked with 5% non-fat milk for 1 to 2 h at room temperature and then probed with primary antibodies and incubated at 4°C overnight. After extensive washing with TBS-T, membranes are incubated with appropriate HRP-conjugated secondary antibody for 1 h at room temperature, and then are detected by Western ECL-enhanced luminol reagent [3].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Cell Assay
    [3]

    A2780 and HO8910 cells are cultured in RPMI 1640, Normal human fibroblasts (NHF) in DMEM, and FTE-187 in M199, supplemented with 10% fetal bovine serum, 100 units/mL penicillin, and 100 mg/mL streptomycin. All the cells are incubated in a humidified atmosphere of 95% air and 5% CO2. Artesunate is applied to the cultured cells at the concentration of 0, 5, 10, 25, or 50 μg/mL for various periods. The reactive oxygen species (ROS) production following Artesunate treatment is determined. Briefly, cells are loaded with 5 μM of CM-H2DCFDA and incubated at 37°C for 20 min after treatment with Artesunate. Cells are resuspended using preserving fluid and analyzed with a FACSCanto II. The peak excitation wavelength for oxidized CM-H2DCFDA is 490 nm and emission is 530 nm[3].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Administration
    [3]

    Four to six weeks old female athymic nude mice (BALB/c, nu/nu) are used. A2780 and HO8910 cells are harvested and resuspended in 0.1 ml of PBS, 5×106 cells/0.2 mL are injected subcutaneously into the left inguinal area of the mice. Two weeks later, mice bearing tumors (~70 mm3 for A2780 and HO8910) are randomly divided into 4 groups. Artesunate is administered daily via i.p. injection at doses of 50 mg/kg alone for 16 days. The tumor growth is monitored every other day. Tumor volume is determined by the formula 1/2a×b2 where a is the long diameter (mm) and b is the short diameter (mm)[3].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    參考文獻

    完整儲備液配制表

    * 請根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲備液;一旦配成溶液,請分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。
    儲備液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C儲存時,請在6個月內(nèi)使用,-20°C儲存時,請在1個月內(nèi)使用。

    可選溶劑 濃度 溶劑體積 質(zhì)量 1 mg 5 mg 10 mg 25 mg
    7.5% Sodium bicarbonate / DMSO 1 mM 2.6013 mL 13.0066 mL 26.0132 mL 65.0330 mL
    5 mM 0.5203 mL 2.6013 mL 5.2026 mL 13.0066 mL
    DMSO 10 mM 0.2601 mL 1.3007 mL 2.6013 mL 6.5033 mL
    15 mM 0.1734 mL 0.8671 mL 1.7342 mL 4.3355 mL
    20 mM 0.1301 mL 0.6503 mL 1.3007 mL 3.2517 mL
    25 mM 0.1041 mL 0.5203 mL 1.0405 mL 2.6013 mL
    30 mM 0.0867 mL 0.4336 mL 0.8671 mL 2.1678 mL
    40 mM 0.0650 mL 0.3252 mL 0.6503 mL 1.6258 mL
    50 mM 0.0520 mL 0.2601 mL 0.5203 mL 1.3007 mL
    60 mM 0.0434 mL 0.2168 mL 0.4336 mL 1.0839 mL
    80 mM 0.0325 mL 0.1626 mL 0.3252 mL 0.8129 mL
    100 mM 0.0260 mL 0.1301 mL 0.2601 mL 0.6503 mL
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    您最近查看的產(chǎn)品:

    Your information is safe with us. * Required Fields.

       產(chǎn)品名稱:

     

    * 需求量:

    * 客戶姓名:

     

    * Email:

    * 電話:

     

    * 公司或機構(gòu)名稱:

       留言給我們:

    Bulk Inquiry

    Inquiry Information

    產(chǎn)品名稱:
    Artesunate
    目錄號:
    HY-N0193
    需求量: